EMDR is a structured, time-limited talk therapy pairing brief focus on traumatic memories with left–right stimulation. For adults with post-traumatic stress, reviews support meaningful symptom reduction comparable to other trauma therapies. Trauma-linked depression, anxiety, and sleep often improve as well. Short-term distress and fatigue are common. Strongest role is when unresolved trauma degrades recovery—not as general wellness care. (Full Review)

Protocol

Course

~6–12 weekly sessions

~50–90 min after preparation; more for complex trauma

Delivery

Trained clinician

Eight-phase, three-pronged model after preparation

Stimulation

Eye movements, taps, or tones

Alternatives when eyes are strained

Time to effect

Trauma symptoms

Over weeks

Broader syndrome change

Single target

1–few sessions

Reduced distress on active memory

Complex trauma

Longer course

Extended preparation and more sessions

Benefits

High: Reduction of PTSD symptoms

Medium: Improvement in trauma-related depression and anxiety symptoms; better sleep quality when PTSD drives insomnia

Low: Reduction of chronic pain intensity in selected patients

Speculative: Downstream reduction of allostatic and cardiovascular risk via trauma resolution

Contraindications

Active suicidal crisis or inability to maintain safety between sessions

Untreated active psychosis or mania with impaired reality testing

Severe dissociation without adequate stabilization

Medical instability making intense autonomic arousal unsafe until cleared (e.g., unstable acute coronary syndrome)

No access to a trained EMDR clinician and inter-session support plan

Key Interactions

Psychiatric medications (SSRIs e.g. sertraline, fluoxetine; SNRIs e.g. venlafaxine, duloxetine; benzodiazepines e.g. lorazepam, clonazepam; prazosin)

Alcohol and recreational drugs

Other trauma therapies (prolonged exposure, cognitive processing therapy) run in parallel without coordination

Supplements with strong sedative or dissociative effects (high-dose kava, heavy sedative herbals)

Stimulants and high caffeine load pre-session

Risk & Side Effects

High: Temporary increase in emotional distress during or between sessions

Medium: Fatigue, headache, dizziness, or other transient physical sensations; vivid dreams, sleep disruption, or increased memory intrusions short-term

Low: Treatment dropout and incomplete courses; symptom exacerbation or re-traumatization with inadequate delivery

Speculative: Rare severe psychiatric decompensation in vulnerable individuals

Monitoring

Marker	Target	Why
PCL-5 (PTSD checklist)	Below clinic cutoff; large reliable change from baseline	Tracks core PTSD symptom burden
Session SUD (0–10)	Toward 0–1 on completed targets	Confirms desensitization of the active memory
VOC (1–7)	Toward 7 on preferred belief for completed targets	Tracks installation of adaptive cognition
PHQ-9 / GAD-7 (or equivalents)	Remission or clear downward trend	Secondary mood/anxiety load
Sleep quality (diary or validated scale)	Improved continuity; fewer trauma nightmares	Trauma often disrupts sleep
Dissociation screen (when indicated)	Stable or reduced; no escalating detachment	Flags need to slow Phase 4 work
Optional: resting HR / HRV trends	Individual improvement vs personal baseline	Rough autonomic stress proxy for bio-trackers
Optional: BP / cardiac follow-up	Per cardiology plan	Relevant if PTSD followed a cardiac event

Cadence: Symptom scales at intake, mid-course, end of acute course, and follow-up (e.g., 1–3 months); in-session SUD/VOC every desensitization target

Qualitative Assessment

Ability to recall formerly hot memories with little bodily alarm
Fewer avoidant behaviors and trauma-linked triggers in daily life
Improved emotional range without constant hypervigilance
More restorative sleep and fewer nightmare awakenings
Restored social and work functioning aligned with personal goals
Confidence using self-regulation skills between sessions

EMDR for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment